ImmunityBio, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
IBRX on Nasdaq
Location
3530 John Hopkins Court, San Diego, CA

There are no Buy or Sell transactions made by insiders since 11/4/2023

ImmunityBio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick Soon Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner $313M Feb 22, 2024
Barry J. Simon Director $10.7M Feb 22, 2024
Richard Adcock CEO & President, Director $2.83M Feb 22, 2024
David C. Sachs Chief Financial Officer $1.12M Feb 22, 2024
John C. Thomas Former Director $1.09M Dec 31, 2021
Regan J. Lauer Chief Accounting Officer $366K Feb 22, 2024
Michael D. Blaszyk Director Jun 11, 2024
John Owen Brennan Director Jun 11, 2024
Wesley Clark Director Jun 11, 2024
Christobel Selecky Director Jun 11, 2024
Linda Maxwell Director Jun 11, 2024
Cheryl Cohen Director Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for ImmunityBio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.